Alibaba Health Information Technology Ltd

00241

Company Profile

  • Business description

    Alibaba Health is of one of China's leading e-commerce platform specializing in healthcare-related products, including prescription drugs, OTC drugs, traditional Chinese medicine, health foods, and so on. The company operates both a third-party B2C service, or 3P, and its own direct-to-consumer business, or 1P, with its own inventory, which can both be accessed by Alibaba’s Tmall app and Alipay. The company also provides online consultation services in a separate app called Yilu or “Dr. Deer,” although its e-commerce businesses remain its core competency in the long-term. E-commerce accounted for 93% of revenue in fiscal year 2022. We estimate that AliHealth holds about 45% of market share in the industry in terms of GMV. AliHealth is 63.74% owned by its parent company, Alibaba Group.

  • Contact

    Guanghua Road
    65th Floor, CITIC Tower, Building 1, No.10 Courtyard
    Jianwai Subdistrict, Chaoyang District
    Beijing
    CHN

    https://www.alihealth.cn

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Pharmaceutical Retailers

    Fiscal Year End

    31 March 2026

    Employees

    1,422

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,571.4040.30-0.47%
CAC 407,829.8380.66-1.02%
DAX 4023,921.90200.50-0.83%
Dow JONES (US)41,860.44816.80-1.91%
FTSE 1008,722.6963.77-0.73%
HKSE23,544.31283.47-1.19%
NASDAQ18,872.64270.07-1.41%
Nikkei 22536,985.87313.11-0.84%
NZX 50 Index12,662.2540.85-0.32%
S&P 5005,844.6195.85-1.61%
S&P/ASX 2008,348.7038.10-0.45%
SSE Composite Index3,380.197.39-0.22%

Market Movers